Callitas Health Signs Product Development and Manufacturing Agreement with LifeStyles
13 févr. 2019 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) a diversified clinical-stage...
Callitas Health Signs Letter of Intent with NuEthix, LLC to Supply CannaStrip Technology in Nutrition and Fitness Segment
07 févr. 2019 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”), an integrated clinical-stage...
Callitas Health, Inc. Releases End-of-Year Update Letter to Shareholders
19 déc. 2018 08h00 HE
|
Callitas Health Inc.
CINCINNATI, OH, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F3), today announced that President and Chief Executive Officer, James...
Callitas Health Announces Passing of Former CEO and President Gary A. Thompson
13 sept. 2018 18h13 HE
|
Callitas Health Inc.
CINCINNATI, OH, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) announced today with great sadness,...
Callitas Health Signs Letter of Intent with Lifestyles to Supply Unique Finished Goods for Retail Sale
14 août 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development...
Callitas Health, Inc. Receives Full US Patent Grant for Treatment for Male Infertility (and Sub-Fertility)
25 juil. 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, July 25, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health Launches Affiliate Network to Expand Reach for ToConceive
10 juil. 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, July 10, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health, Inc. Signs Non-Exclusive Licensing Agreement for Patented Arousal Gel Technology & Products with LifeStyles, LTD
26 juin 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH & SOUTH ISELIN, NJ, June 26, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical...
James Thompson Elevated to President and Chief Executive Officer of Callitas Health, Inc.
07 juin 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, June 07, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...
Dr. Gregory Smith MD, MPH, Chief Medical Cannabis Advisor for Callitas Health, Releases New Book on THCV
05 juin 2018 10h32 HE
|
Callitas Health Inc.
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...